BioMarin Pharmaceutical Inc. Falling On The Genzyme News

Posted on 11/13/09 at 11:57am by Benzinga Staff

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) is falling some 4% on news that some Genzyme drugs could be contaminated.

BioMarin Pharma has three approved products and multiple investigational product candidates.

Bookmark/Search this post with:
  • Twitter
  • Facebook
  • Buzz Up!
  • StumbleUpon
  • Digg
  • Reddit
  • MySpace
  • LinkedIn
  • del.icio.us
You are not watching this post, click to start watching

Posted in
There are 0 comments
Please note that comments may take up to one hour before they get published on the site. Please check back later to see your comments.

Post new comment

The content of this field is kept private and will not be shown publicly.